Bisoprolol in the treatment of chronic heart failure

References

• BaxterAJSpensleyAHildrethABeta blockers in older persons with heart failure: tolerability and impact on quality of lifeHeart200288611412433890
   PubMed Web of Science ®Google Scholar
• BundkirchenABrixiusKBolckBBeta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studiesEur J Pharmacol2003460192612535855
   PubMed Web of Science ®Google Scholar
• ChatterjeeSSThe cardioselective and hypotensive effects of bisoprolol in hypertensive asthmaticsJ Cardiovasc Pharmacol19868Suppl 11S7472439803
   PubMed Web of Science ®Google Scholar
• CIBIS-II Investigators and CommitteesThe Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet1999353913
   PubMed Web of Science ®Google Scholar
• CIBIS Investigators and CommitteesA randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS)Circulation1994901765737923660
   PubMed Web of Science ®Google Scholar
• ClelandJGDaubertJCErdmannEThe effect of cardiac resynchronization on morbidity and mortality in heart failureN Engl J Med200535215394915753115
   PubMed Web of Science ®Google Scholar
• de GrootePDelourPLamblinNEffects of bisoprolol in patients with stable congestive heart failureAnn Cardiol Angeiol (Paris)2004531677015369311
   PubMedGoogle Scholar
• DorowPBethgeHTonnesmannUEffects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectorisEur J Clin Pharmacol19863114372879733
   PubMed Web of Science ®Google Scholar
• DubachPMyersJBonettiPEffects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial taggingAm Heart J20021436768311923805
   PubMed Web of Science ®Google Scholar
• EnnezatPVEnnezatCAVijayaramanPDissociation between improvement in left ventricular performance and functional class in patients with chronic heart failureJ Cardiovasc Pharmacol200546262816116329
   PubMed Web of Science ®Google Scholar
• ErdmannELechatPVerkennePResults from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failureEur J Heart Fail200134697911511434
   PubMed Web of Science ®Google Scholar
• FlatherMDShibataMCCoatsAJRandomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)Eur Heart J2005262152515642700
   PubMed Web of Science ®Google Scholar
• Funck-BrentanoCLancarRHansenSPredictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2)Am Heart J20011429899711717602
   PubMed Web of Science ®Google Scholar
• Funck-BrentanoCLancarRLe HeuzeyJYPredictors of medical events in patients enrolled in the cardiac insufficiency bisoprolol study (CIBIS): a study of the interactions between beta-blocker therapy and occurrence of critical events using analysis of competitive risksAm Heart J20001392627110650299
   PubMed Web of Science ®Google Scholar
• GalatiusSGustafssonFAtarDTolerability of beta-blocker initiation and titration with bisoprolol and carvedilol in congestive heart failure — a randomized comparisonCardiology2004102160515334027
   PubMed Web of Science ®Google Scholar
• HuntSAAbrahamWTChinMHACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm SocietyCirculation2005112e15423516160202
   PubMed Web of Science ®Google Scholar
• KirchWRoseIDemersHGPharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver diseaseClin Pharmacokinet19871311072887325
   PubMed Web of Science ®Google Scholar
• LechatPHulotJSEscolanoSHeart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II TrialCirculation200110314283311245648
   PubMed Web of Science ®Google Scholar
• LeizoroviczALechatPCucheratMBisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies—CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol StudyAm Heart J2002143301711835035
   PubMed Web of Science ®Google Scholar
• LeopoldGPabstJUngethumWBasic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonistJ Clin Pharmacol198626616212878941
   PubMed Web of Science ®Google Scholar
• McGavinJKKeatingGMBisoprolol: a review of its use in chronic heart failureDrugs20026226779612466013
   PubMed Web of Science ®Google Scholar
• MERIT-HF study groupEffect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)The Lancet199935320017
   PubMed Web of Science ®Google Scholar
• PackerMCoatsAJFowlerMBEffect of carvedilol on survival in severe chronic heart failureN Engl J Med20013441651811386263
   PubMed Web of Science ®Google Scholar
• PfefferMABraunwaldEMoyeLAEffect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE InvestigatorsN Engl J Med1992327669771386652
   PubMed Web of Science ®Google Scholar
• PittBZannadFRemmeWJfor the Randomized Aldactone Evaluation Study InvestigatorsThe effect of spironolactone on morbidity and mortality in patients with severe heart failureN Engl J Med19993417091710471456
   PubMed Web of Science ®Google Scholar
• Poole-WilsonPASwedbergKClelandJGComparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialLancet200336271312853193
   PubMed Web of Science ®Google Scholar
• SchuchertAEffects of bisoprolol treatment for chronic heart failure initiated and followed up by primary care physiciansEur J Heart Fail200576041115921801
   PubMed Web of Science ®Google Scholar
• SimonTMary-KrauseMFunck-BrentanoCBisoprolol dose-response relationship in patients with congestive heart failure: a sub-group analysis in the cardiac insufficiency bisoprolol study(CIBIS II)Eur Heart J200324552912643888
   PubMed Web of Science ®Google Scholar
• SmithCTeitlerMBeta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptorsCardiovasc Drugs Ther199913123610372227
   PubMed Web of Science ®Google Scholar
• SwedbergKClelandJDargieHGuidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of CardiologyEur Heart J20052611154015901669
   PubMed Web of Science ®Google Scholar
• SwedbergKHjalmarsonAWaagsteinFProlongation of survival in congestive cardiomyopathy by beta-receptor blockadeLancet197911374687834
   PubMed Web of Science ®Google Scholar
• The Beta-Blocker Evaluation of Survival Trial InvestigatorsA trial of the beta-blocker bucindolol in patients with advanced chronic heart failureN Engl J Med200134416596711386264
   PubMed Web of Science ®Google Scholar
• The CONSENSUS Trial Study GroupEffects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)N Engl J Med19873161429352883575
   PubMed Web of Science ®Google Scholar
• The SOLVD InvestigatorsEffect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD InvestigatorsN Engl J Med19913252933022057034
   PubMed Web of Science ®Google Scholar
• The SOLVD InvestigatorsEffect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD InvestigattorsN Engl J Med1992327685911463530
   PubMed Web of Science ®Google Scholar
• WaagsteinFHjalmarsonAVarnauskasEEffect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathyBr Heart J1975371022361191416
   PubMedGoogle Scholar
• WellsteinAPalmDBelzGGConcentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assayJ Cardiovasc Pharmacol19868Suppl 11S4152439797
   PubMedGoogle Scholar
• WillenheimerRvan VeldhuisenDJSilkeBEffect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) IIICirculation200511224263516143696
   PubMed Web of Science ®Google Scholar